News

Published on 29 Feb 2024 on Zacks via Yahoo Finance

New Strong Buy Stocks for February 29th

Article preview image

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Ultrapar Participações S.A. UGP: This energy and infrastructure company has seen the Zacks Consensus Estimate for its current year earnings increasing 31.8% over the last 60 days.

Ultrapar Participacoes S.A. Price and Consensus

Read the rest of the article
NYSE.UGP price evolution
NASDAQ.KNSA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript April 23, 2024 Kinik...

Insider Monkey · via Yahoo Finance 29 Apr 2024
Analyst Estimates: Here's What Brokers Think Of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) After...

It's been a good week for Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) shareholders, because the c...

Simply Wall St. via Yahoo Finance 26 Apr 2024
Earnings call: Kiniksa Pharmaceuticals sees 85% revenue surge in Q1 2024 By Investing.com

Kiniksa Pharmaceuticals (NASDAQ:KNSA) has reported a significant increase in its financial...

Investing.com 24 Apr 2024
Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q1 Loss, Tops Revenue Estimates

Kiniksa Pharmaceuticals, Ltd. (KNSA) came out with a quarterly loss of $0.25 per share versus the...

Zacks via Yahoo Finance 23 Apr 2024
Earnings call: Kiniksa Pharmaceuticals sees robust growth in ARCALYST sales By Investing.com

Kiniksa Pharmaceuticals (NASDAQ:KNSA) has reported substantial growth in the fourth quarter and...

Investing.com 1 Mar 2024
Does Kiniksa Pharmaceuticals, Ltd. (KNSA) Have the Potential to Rally 32.45% as Wall Street Analysts...

Kiniksa Pharmaceuticals, Ltd. (KNSA) closed the last trading session at $21.14, gaining 16.1% ove...

Zacks via Yahoo Finance 1 Mar 2024
Earnings call: Kiniksa Pharmaceuticals sees robust growth in ARCALYST sales By Investing.com

Kiniksa Pharmaceuticals (NASDAQ:KNSA) has reported substantial growth in the fourth quarter and...

Investing.com 1 Mar 2024
Chief Medical Officer John Paolini Sells 10,156 Shares of Kiniksa Pharmaceuticals Ltd (KNSA)

Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA), a biopharmaceutical company focused on the discovery, ...

GuruFocus.com via Yahoo Finance 29 Feb 2024
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2023 Earnings Call Transcript

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2023 Earnings Call Transcript February 28, 2024 Ki...

Insider Monkey via Yahoo Finance 29 Feb 2024
New Strong Buy Stocks for February 29th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Ultrapar Participações S...

Zacks via Yahoo Finance 29 Feb 2024

Copyright Statfolio @ 2025

Social Accounts